Press "Enter" to skip to content

FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation

Today, the FDA approved a new treatment for Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy (DMD) patients

Original source: http://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation

Also Read:   FDA, DEA seize 44 websites advertising sale of illicit THC vaping cartridges to US consumers as part of Operation Vapor Lock